Patents Assigned to Synova Life Sciences, Inc.
  • Patent number: 12281331
    Abstract: Methods provided by the present disclosure utilize extracorporeal shockwaves, mechanical impacts and/or principles of lithotripsy to break up a tissue sample into smaller fragments—clusters of cells and/or single cells—after which a desired cellular fraction can be isolated from the sample. Devices provided by the present disclosure deploy focused and/or directed shockwaves, and/or focused and directed mechanical impacts, to break apart a tissue sample. The devices maintain the sample in a sterile, closed environment during exposure to the shockwaves or mechanical impacts. Therefore, the shockwaves and/or mechanical impacts are generated outside of a closed device and are transmitted through one or more walls of the device into its interior, where the sample is located.
    Type: Grant
    Filed: November 13, 2023
    Date of Patent: April 22, 2025
    Assignee: Synova Life Sciences, Inc.
    Inventors: John Chi, Ben-Chen Chi
  • Patent number: 11866732
    Abstract: Methods provided by the present disclosure utilize extracorporeal shockwaves, mechanical impacts and/or principles of lithotripsy to break up a tissue sample into smaller fragments—clusters of cells and/or single cells—after which a desired cellular fraction can be isolated from the sample. Devices provided by the present disclosure deploy focused and/or directed shockwaves, and/or focused and directed mechanical impacts, to break apart a tissue sample. The devices maintain the sample in a sterile, closed environment during exposure to the shockwaves or mechanical impacts. Therefore, the shockwaves and/or mechanical impacts are generated outside of a closed device and are transmitted through one or more walls of the device into its interior, where the sample is located.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: January 9, 2024
    Assignee: Synova Life Sciences, Inc.
    Inventors: John Chi, Ben-Chen Chi
  • Patent number: 10329533
    Abstract: An adipose-derived stem cell (ASC), regenerative cell and/or regenerative factor processing system including a tissue extraction device for extracting raw tissue, such as adipose tissue, from a patient, an ASC, regenerative cell and/or regenerative factor isolator, and an implantation device for re-introducing the isolated ASCs, regenerative cells and/or regenerative factors into the patient.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: June 25, 2019
    Assignee: Synova Life Sciences, Inc.
    Inventors: John Chi, James Lee